Molecular Modeling, de novo Design and Synthesis of a Novel, Extracellular Binding Fibroblast Growth Factor Receptor 2 Inhibitor Alofanib (RPT835)

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|12|4|303-317

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.12, Iss.4, 2016-06, pp. : 303-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor Receptor Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite

Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells

By Terada Takeshi   Mizobata Miki   Kawakami Shigeru   Yabe Yoshiyuki   Yamashita Fumiyoshi   Hashida Mitsuru  

Journal of Drug Targeting, Vol. 14, Iss. 8, 2006-09 ,pp. : 536-545

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration

By Woodbury Maya   Ikezu Tsuneya  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 92-101

Springer Publishing Company

Access to resources Recommend Favorite

OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

By Tsimafeyeu Ilya   Zaveleva Elina   Stepanova Evgenia   Low Walter  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1436-1443

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Modeling in Cysteine Protease Inhibitor Design

By  

Current Pharmaceutical Design, Vol. 8, Iss. 18, 2002-08 ,pp. : 1673-1681

Bentham Science Publishers

Access to resources Recommend Favorite